The EPIPSOFIRE project: A Preliminary Report

Gabriele De Marco, Angelo Cattaneo, Carlo G. Carrera, Patrizia Gibertini, Norma Battafarano, Antonio Marchesoni

Research output: Contribution to journalArticle

Abstract

Postmarketing Phase IV Psoriatic arthritis (PsA) is a musculoskeletal condition complicating psoriasis that can lead to joint deformity and disability; however, psoriatic patients may suffer from other kind of arthropathies that could be confused with PsA by nonrheumatologists. Our aim was to determine the prevalence of PsA and to determine the prevalence of other musculoskeletal conditions in a cohort of psoriatic patients. In this cohort, musculoskeletal discomfort was frequently reported, while inflammatory disorders were detected in 20 years) or severe cutaneous disease. Because musculoskeletal discomfort symptoms affected about 62% of patients, other disorders, particularly morphologic conditions, need careful evaluation in psoriasis subjects.

Original languageEnglish
Pages (from-to)S85-S87
JournalDrug Development Research
Volume75
DOIs
Publication statusPublished - 2014

Keywords

  • multidisciplinary approach to psoriasis care
  • musculoskeletal discomfort
  • psoriatic arthritis

ASJC Scopus subject areas

  • Drug Discovery
  • Medicine(all)

Fingerprint Dive into the research topics of 'The EPIPSOFIRE project: A Preliminary Report'. Together they form a unique fingerprint.

  • Cite this

    De Marco, G., Cattaneo, A., Carrera, C. G., Gibertini, P., Battafarano, N., & Marchesoni, A. (2014). The EPIPSOFIRE project: A Preliminary Report. Drug Development Research, 75, S85-S87. https://doi.org/10.1002/ddr.21205